🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

CHEPLAPHARM Arzneimittel GmbH — Licensed Medicines

74 medicines held by CHEPLAPHARM Arzneimittel GmbH on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 74 products held by CHEPLAPHARM Arzneimittel GmbH
MedicineActive substanceLicence holderStatus
Seroquel 100 mg film-coated tablets
PA2239/022/002
Quetiapine CHEPLAPHARM Arzneimittel GmbH Marketed
Seroquel 25 mg film-coated tablets
PA2239/022/001
Quetiapine CHEPLAPHARM Arzneimittel GmbH Marketed
Seroquel XR 150mg prolonged-release tablets
PA2239/022/006
Quetiapine CHEPLAPHARM Arzneimittel GmbH Marketed
Seroquel XR 200mg prolonged-release tablets
PA2239/022/007
Quetiapine CHEPLAPHARM Arzneimittel GmbH Marketed
Seroquel XR 300mg prolonged-release tablets
PA2239/022/008
Quetiapine CHEPLAPHARM Arzneimittel GmbH Marketed
Seroquel XR 400mg prolonged-release tablets.
PA2239/022/009
Quetiapine CHEPLAPHARM Arzneimittel GmbH Marketed
Seroquel XR 50 mg prolonged-release tablets
PA2239/022/005
Quetiapine CHEPLAPHARM Arzneimittel GmbH Marketed
Tandemact
EU/1/06/366/005-16
Glimepiride, Pioglitazone CHEPLAPHARM Arzneimittel GmbH
Tandemact
EU/1/06/366/17-22
Glimepiride, Pioglitazone hydrochloride CHEPLAPHARM Arzneimittel GmbH
Valcyte 450 mg film-coated tablets
PA2239/023/001
Valganciclovir hydrochloride CHEPLAPHARM Arzneimittel GmbH Marketed
Valcyte 50 mg/ml powder for oral solution
PA2239/023/002
Valganciclovir hydrochloride CHEPLAPHARM Arzneimittel GmbH Marketed
VEPESID 100 mg capsule, soft
PA2239/006/002
Etoposide CHEPLAPHARM Arzneimittel GmbH Marketed
VEPESID 50 mg capsule, soft
PA2239/006/001
Etoposide CHEPLAPHARM Arzneimittel GmbH Marketed
Vesanoid 10 mg soft capsules
PA1868/001/001
Tretinoin Cheplapharm Arzneimittel GmbH Marketed
Visudyne 15 mg powder for solution for infusion
EU/1/00/140/001
Verteporfin CHEPLAPHARM Arzneimittel GmbH
Xeloda 150 mg film-coated tablets
EU/1/00/163/001
Capecitabine Cheplapharm Arzneimittel GmbH
Xeloda 500 mg film-coated tablets
EU/1/00/163/002
Capecitabine Cheplapharm Arzneimittel GmbH
Xenical 120 mg hard capsules
EU/1/98/071/001
Orlistat Cheplapharm Arzneimittel GmbH
Xenical 120 mg hard capsules
EU/1/98/071/002
Orlistat CHEPLAPHARM Arzneimittel GmbH
Xenical 120 mg hard capsules
EU/1/98/071/003
Orlistat Cheplapharm Arzneimittel GmbH
Xenical 120 mg hard capsules
EU/1/98/071/004
Orlistat Cheplapharm Arzneimittel GmbH
Xenical 120 mg hard capsules
EU/1/98/071/005
Orlistat Cheplapharm Arzneimittel GmbH
Xenical 120 mg hard capsules
EU/1/98/071/006
Orlistat Cheplapharm Arzneimittel GmbH
Zineryt 40 mg + 12 mg powder and solvent for cutaneous solution
PA2239/018/001
Erythromycin, Zinc acetate dihydrate CHEPLAPHARM Arzneimittel GmbH Marketed
1 2

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.